St. Thomas University in Minnesota is building a new building for its Center for Microgrid Research facility on the St. Paul ...
From extending the life of the Monticello nuclear plant to building one of the nation’s largest solar farms at Sherco, Xcel ...
Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...
Edinburgh, Indiana / / September 2, 2025 / Midwest Engines & Generators (MEG) When a facility plans for backup or prime power ...
French biotech Pharnext has seen the value of its shares collapse after it revealed that its lead drug, a treatment for Charcot-Marie-Tooth (CMT) disease, failed to make the grade in a phase 3 trial.
Copyright: © 2024 The Author(s). Published by Elsevier Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results